Zobrazeno 1 - 10 of 26 pro vyhledávání: '"Renata Eiras"'
1
Akademický článek
Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting
Autor: Shirish M. Gadgeel, Pragya Rai, Srinivas Annavarapu, Sartaj Alam, Jerome H. Goldschmidt, Howard (Jack) West, Melissa Santorelli, Renata Eiras Martins
Publikováno v: Frontiers in Oncology, Vol 14 (2024)
BackgroundThis study investigated real-world time on treatment (rwToT) and overall survival (OS) for patients with metastatic non-small cell lung cancer (mNSCLC) who initiated first-line (1L) pembrolizumab monotherapy. We also explored discontinuatio
Externí odkaz: https://doaj.org/article/9b3a9a0770cd434b8b46c82596f9dd6b
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Abstract CT067: Pembrolizumab with and without sacituzumab govitecan as first-line treatment for metastatic non-small-cell lung cancer (NSCLC) with PD-L1 TPS ≥50%: phase 3 KEYNOTE-D46/EVOKE-03 study
Autor: Mor Moskovitz, Isamu Okamoto, Peng Chen, Jilpa Patel, Sabeen Mekan, M. Catherine Pietanza, Yalin Zhu, Renata Eiras, Marcello Tiseo
Publikováno v: Cancer Research. 83:CT067-CT067
Background: Sacituzumab govitecan is an antibody-drug conjugate comprising an anti-trophoblast cell-surface antigen 2 (Trop-2) antibody coupled to a potent payload, SN-38, via a proprietary, hydrolysable linker. In heavily pretreated patients with me
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ee8f437f3c19f1d5fbb3cdea5226eb0
https://doi.org/10.1158/1538-7445.am2023-ct067
Zobrazit plný text záznamu
5
Dissertation/ Thesis
Avaliação do risco de complicações decorrentes de neutropenia febril em pacientes tratados no Instituto do Câncer do Estado de São Paulo
Autor: Martins, Renata Eiras
INTRODUÇÃO: Neutropenia febril (NF) é frequente complicação quimioterapia para tumores sólidos e é de suma importância a identificação dos pacientes de alto risco para o seu desenvolvimento. OBJETIVOS: Caracterização clínica, laboratoria
Externí odkaz: http://www.teses.usp.br/teses/disponiveis/5/5155/tde-29102014-160517/
Zobrazit plný text záznamu
8
Cystic brain metastases in ALK-rearranged non-small cell lung cancer
Autor: Renata Colombo Bonadio, Henrique Bortot Zuppani, Gilberto de Castro Junior, Guilherme Nader Marta, Renata Eiras Martins
Publikováno v: ecancermedicalscience
The central nervous system (CNS) is a common site of disease progression in patients with non-small-cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK)-rearrangement treated with crizotinib. Cystic brain metastases (CBM) have been recently
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1092284c9a6a2bf011c6876dbf6fdd08
http://europepmc.org/articles/PMC5880229
Zobrazit plný text záznamu
10
Cachexia in head and neck squamous cell carcinoma (HNSCC) patients (pts) after cisplatin-based chemoradiation (CRT): A cross-sectional study
Autor: Renata Eiras Martins, Willian das Neves, Eduardo Furquim Simao, Marco Aurélio Vamondes Kulcsar, Thomas Giollo Rivelli, Gilberto de Castro
Publikováno v: Journal of Clinical Oncology. 37:e23138-e23138
e23138 Background: Cachexia is a wasting syndrome that may affect HNSCC pts, contributing to their dismal prognosis. We aimed to study the frequency of cachexia in HNSCC survivors treated with CRT with curative intent. Methods: Cross-sectional study
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::151b904318d0b7f8e061ca12944d76c4
https://doi.org/10.1200/jco.2019.37.15_suppl.e23138
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje